← back to search

Hironori Nakagami

University Child Development School · JP
🔎 Find collaborators in Molecular Biology · Infectious Diseases →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Infectious Diseases
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Atherosclerosis and Cardiovascular Diseases, Angiogenesis and VEGF in Cancer, and Bone Metabolism and Diseases.
h-index
56
citations
11,801
works
409
NIH funding
primary concept
Medicine
email

Recent publications

A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts.
2025cited by 13position: contributordoi
For early diagnosis of young patients with Werner syndrome: Indication for genetic testing.
2025cited by 1position: contributordoi
Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7.
2024cited by 26position: contributordoi
PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis
The EMBO Journal 2024cited by 12position: middledoi
PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis.
2024cited by 8position: contributordoi
Therapeutic Vaccines and Nucleic Acid Drugs for Cardiovascular Disease.
2024cited by 2position: contributordoi
Recommendations for cancer screening and surveillance in patients with Werner syndrome.
2024cited by 2position: contributordoi
Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies
eLife 2024cited by 2position: contributordoi
Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet Injector.
2024cited by 1position: contributordoi
Preventive effects of vasohibin-2-targeting peptide vaccine for diabetic nephropathy.
2024cited by 1position: contributordoi
Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies.
2024cited by 1position: contributordoi
Author Response: Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies
2024cited by 0position: contributordoi
Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies
2024cited by 0position: contributordoi
Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies
2024cited by 0position: contributordoi
Author response: Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies
2024cited by 0position: contributordoi
Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study.
2023cited by 22position: contributordoi
Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine.
2023cited by 6position: contributordoi
R-spondin 3/LGR4 (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4) Axis Is a Novel Inflammatory and Neurite Outgrowth Signaling System in the Ischemic Brain in Mice.
2023cited by 5position: contributordoi
Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19).
2023cited by 3position: contributordoi
Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021.
2023cited by 0position: contributordoi
Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies
2023cited by 0position: contributordoi
Author Response: Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies
2023cited by 0position: contributordoi
Supplementary Figure 1-7 from Antiproliferative Effects of Monoclonal Antibodies against (Pro)Renin Receptor in Pancreatic Ductal Adenocarcinoma
2023cited by 0position: contributordoi
Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies
2023cited by 0position: contributordoi
Data from Antiproliferative Effects of Monoclonal Antibodies against (Pro)Renin Receptor in Pancreatic Ductal Adenocarcinoma
2023cited by 0position: contributordoi
Supplementary Figure 1-7 from Antiproliferative Effects of Monoclonal Antibodies against (Pro)Renin Receptor in Pancreatic Ductal Adenocarcinoma
2023cited by 0position: contributordoi
Data from Antiproliferative Effects of Monoclonal Antibodies against (Pro)Renin Receptor in Pancreatic Ductal Adenocarcinoma
2023cited by 0position: contributordoi
Preclinical study of a DNA vaccine targeting SARS-CoV-2.
2022cited by 17position: contributordoi
Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults.
2022cited by 12position: contributordoi
RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages.
2022cited by 10position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 53 papers (2019–2025)Masaya Koshizaka · Japanese Red Cross Narita Hospital10 papers (2021–2025)Minoru Takemoto · International University of Health and Welfare10 papers (2019–2025)Ryuichi Morishita · Osaka Metropolitan University10 papers (2013–2025)Xiuyuan Lu · Beijing Forestry University9 papers (2023–2024)Sho Yamasaki · Microbial Chemistry Research Foundation9 papers (2023–2024)Hiromi Rakugi · Tokyo Rosai Hospital9 papers (2014–2025)Hiroki Hayashi · Osaka University8 papers (2020–2025) · 7 papers (2019–2025)Eri Ishikawa · The University of Osaka7 papers (2023–2024)Shota Yoshida · Osaka University7 papers (2020–2025)Munehisa Shimamura · Osaka Gakuin University7 papers (2019–2025) · 6 papers (2020–2025)Akira Nishiyama · Japanese Society of Hypertension5 papers (2020–2023) · 5 papers (2020–2023)Akio Ebihara · RIKEN5 papers (2020–2023)Arif Ul Hasan · Iwate Medical University5 papers (2020–2023)Hiroki Hayashi · Faculty of Medicine, Kagawa University5 papers (2020–2023)Asadur Rahman · International University of Health and Welfare5 papers (2020–2023)Hisashi Arase · Kobe University4 papers (2020–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Infectious Diseases →